Subscribe to Newsletter

Refine results:

Refine results

Upcoming Webinars

Diagnostics Liquid biopsy

Implementing liquid biopsy testing in a routine lab

, 11:00AM ET | Sponsored by Labcorp

The goal of this webinar is to share the learnings around the ease of onboarding a liquid biopsy solution in a laboratory setting

Diagnostics Oncology

Multicenter study of the Oncomine Comprehensive Assay Plus for local comprehensive molecular profiling

, 5pm CET | Sponsored by Thermo Fisher Scientific

In this webinar, Dr. Jantus-Lewintre shares her lab's experience evaluating the Oncomine Comprehensive Assay Plus

Diagnostics Oncology

Rapid molecular profiling is essential to optimize patient outcomes - Real-world data analysis

| Sponsored by Thermo Fisher Scientific

In their retrospective study Integra Connect investigated how this behavior affects outcomes.

Subspecialties Oncology

Addressing the incomplete mutational landscape in pediatric cancers with Optical Genome Mapping

, 11am ET | Sponsored by Bionano

In this Bionano in Motion webinar, we explore the utility and validity of an innovative strategy, proposed by Dr Brandes from Heinrich-Heine University and University Hospital Dusseldorf that combines Optical Genome Mapping (OGM) and whole exome sequencing (WES) in 60 HD and ETV6::RUNX1+ BCP-ALL cases. This study shows that OGM detected a high number of additional SVs not identified using the conventional methods, including (subclonal) IKZF1 deletions, a prognostically relevant subtype.

Subspecialties Oncology

Elevating the Standard of Pathogenic Variant Detection in Myeloid Cancers

| Sponsored by Bionano

In this Bionano in Motion webinar, we explore the utility and validity of an innovative strategy, proposed by Dr. Kolhe’s lab, from Augusta University, that combines optical genome mapping (OGM) with a comprehensive 523-gene next-generation sequencing (NGS) panel. This unique approach was meticulously evaluated against more traditional methods including karyotyping, fluorescent in situ hybridization (FISH), and a 54-gene NGS panel.

Subspecialties Microbiology and immunology

Spatial analysis of human lung cancer reveals organized immune hubs enriched for stem-like CD8 T cells and associated with immunotherapy response

| Sponsored by Vizgen

We are thrilled to invite you to our upcoming online webinar, where we will delve into groundbreaking research on the spatial organization of immune cells in human tumors and its impact on immunotherapy outcomes.

Diagnostics Liquid biopsy

Clinical implications of comprehensive genomic profiling on liquid biopsy for lung cancer patients

| Sponsored by Illumina

In this webinar, Dr Federico Cappuzzo will speak about clinical implications of liquid biopsy-based CGP for lung cancer patients, discussing current clinical evidence and sharing his vision on future applications.

Diagnostics COVID-19

Using Single-Cell Sequencing to Investigate Murine COVID-19 Mortality

| Sponsored by Illumina, Parse Bio

Join Illumina and Parse Biosciences for a webinar where our invited speaker will present results of his recent single-cell study.

Subspecialties Oncology

Adjuvant COX Inhibition Augments Cytolytic T Cell Infiltration in Irradiated Triple Negative Breast Tumors

| Sponsored by Ultivue

Immune therapy has emerged as the new frontier of cancer treatment.

Subspecialties Oncology

Identifying HER2-low expression – A pathologist led slide review

| Sponsored by Roche

Roche Tissue Diagnostics invites you to learn more about the importance of identifying each level of HER2 expression.

Subspecialties Oncology

The association between the tumor immune microenvironment and clinical outcome in low-grade, early-stage endometrial cancer patients

, 15:00 GMT | Sponsored by Akoya Biosciences

In this webinar we will discuss the use of the PhenoImager HT (Akoya Biosciences) platform to dissect the immune microenvironment of low-grade early-stage endometrial carcinomas.

Diagnostics Omics

Unlocking Precision Oncology with Genomics - ESMO Roundtable

, 13:00 GMT | Sponsored by Illumina

From the European Society of Medical Oncology (ESMO) 2022 Conference in Paris, a roundtable discussion on the clinical impact of Comprehensive Genomic Profiling.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine